Correction: Synthesis, characterization, DNA interaction, and anticancer studies of novel facial tricarbonylrhenium(i) complexes with uracil-derived ligands
Shabaaz Abdullah, Candace Davison, Christie Jane Smit, Phiwokuhle Mbatha, Jo-Anne de la Mare, Irvin Noel Booysen
TL;DR
This paper corrects a previously published study on new rhenium complexes with potential anticancer properties.
Contribution
The paper provides a correction to prior research on facial tricarbonylrhenium(i) complexes with uracil-derived ligands.
Findings
The correction addresses errors in the original publication.
It ensures accurate synthesis and characterization details of the rhenium complexes.
Abstract
Correction for ‘Synthesis, characterization, DNA interaction, and anticancer studies of novel facial tricarbonylrhenium(i) complexes with uracil-derived ligands’ by Shabaaz Abdullah et al., RSC Adv., 2025, 15, 34635–34642, https://doi.org/10.1039/D5RA05387K.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNanoplatforms for cancer theranostics · Radiopharmaceutical Chemistry and Applications · Click Chemistry and Applications